skip to content
Primary navigation


Drug - Ragwitek™ (short ragweed pollen allergen extract) [Merck Sharp & Dohme Corp.]

November 2014

Therapeutic area - Allergy therapy

Approval criteria

  • Patient must be 18 years of age or older AND
  • Patient has had a skin test positive to short ragweed pollen AND
  • Patient has tried and failed at least one drug out of 2 of the 3 following classes in the last 730 days: intranasal corticosteroids, oral antihistamines, leukotriene receptor antagonists OR
  • Patient has tried allergen-specific immunotherapy injections in the last 730 days

Quantity limits

34 tablets per 34 days


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top